Lv4
472 积分 2024-01-08 加入
The role of IL 23 in the treatment of psoriasis
4个月前
已完结
Psoriasis: from Pathogenesis to Targeted Therapies
4个月前
已完结
Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279
4个月前
已完结
CD30+ High Grade Neoplasm With Expression of β‐HCG and T‐Cell Markers: Hybrid Germ Cell Tumor and T‐Cell Lymphoma?
4个月前
已完结
SOHO State of the Art Updates and Next Questions | Peripheral T-Cell Lymphoma: Current Landscape and Emerging Questions
5个月前
已关闭
Treatment of older adults with peripheral T cell lymphoma (PTCL) amidst a changing therapeutic landscape: a 20-year single institution experience
6个月前
已完结
Pharmacodynamics and pharmacokinetics of DWP14012 (fexuprazan) in healthy subjects with different ethnicities
6个月前
已完结
Randomised clinical trial: Safety, tolerability, pharmacodynamics and pharmacokinetics of zastaprazan (JP‐1366), a novel potassium‐competitive acid blocker, in healthy subjects
6个月前
已完结
Randomized, Double-Blind, Active-Controlled Phase 3 Study to Evaluate Efficacy and Safety of Zastaprazan Compared With Esomeprazole in Erosive Esophagitis
6个月前
已完结
Biopharmaceutical Switching in Psoriasis Treatment
7个月前
已完结
皖公网安备34019202002308
